期刊文献+

C-erbB-2和VEGF在鼻腔-鼻窦鳞状细胞癌中的表达及临床意义 被引量:2

Expression and significance of C-erbB-2 and VEGF in sinonasal squamous cell carcinoma
下载PDF
导出
摘要 目的研究原癌蛋白(C-erb B-2)及血管内皮生长因子(VEGF)在鼻腔、鼻窦鳞状细胞癌(SNSCC)中的表达及其临床意义。方法收集62例SNSCC组织、30例鼻息肉组织(NP组)以及25例正常鼻腔黏膜(正常组),用免疫组化及Western blot技术分别检测C-erb B-2和VEGF在三者中的表达情况。结果 C-erb B-2和VEGF在SNSCC组织中的表达明显高于鼻息肉及正常鼻腔黏膜中的表达(P<0.05)。另外,C-erb B-2和VEGF的表达与病理类型、临床病理分期及淋巴结转移等临床病理特征呈正相关(P<0.05),而与性别、年龄无关。结论 C-erb B-2和VEGF与SNSCC的发生、分化及细胞增殖密切相关,联合检测二者有助于对SNSCC的诊断与治疗。 Objective To explore the expression and significance of C-erb B-2 and vascular endothelial growth factor( VEGF) in sinonasal squamous cell carcinoma( SNSCC). Methods Immuno-histochemical method and Western blot were used to determine the expression of C-erb B-2 and VEGF in specimen of sixty-two cases of sinonasal squamous cell carcinoma( SNSCC),thirty cases of nasal polyps ﹙ NP ﹚ and twenty-five cases of normal nasal mucosa. Results The expression of C-erb B-2 and VEGF in SNSCC was significantly higher than that in nasal polyps﹙ NP ﹚ and normal nasal mucosa( P〈 0. 0 5). Furthermore,the expression of C-erb B-2 and VEGF correlated with tumor classification,clinicopathologic stage,lymph node involvement( P〈 0. 0 5),but not patient's age and gender.Conclusions C-erb B-2 and VEGF are closely related to the tumorigenesis,differentiation and proliferation of SNSCC. Combined detection of these protein may support to diagnose and treatment of SNSCC.
出处 《基础医学与临床》 CSCD 2016年第10期1407-1411,共5页 Basic and Clinical Medicine
关键词 鼻腔、鼻窦肿瘤 鳞状细胞癌 C-ERB B-2 血管内皮生长因子 sinonasal neoplasms squamous cell carcinoma C-erb B-2 vascular endothelial growth factor
  • 相关文献

参考文献9

  • 1唐智,孙瑾,王继群,李玉兰,陈勇明,涂智峰.鼻腔鼻窦鳞状细胞癌中以CD34标记微血管密度的测定[J].广东医学,2013,34(22):3443-3445. 被引量:6
  • 2Jach R, Dulinska-litewka J, Laidler P, et al. Expression of VEGF,VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix [J]. Front Biosci ,2010,2:411-423.
  • 3. Ansa B, Goodman M, Ward K, et al. Paranasal sinus squa- mous cell carcinomar incidence and survival based on Sur- veillance, Epidemiology, and End Results data, 1973 to 2009 [ J ]. Cancer, 2013,119 : 2602- 2610.
  • 4Saglam O, Husain S,Toruner G. AKI, EGFR, C-erbB-2 and C-kit expression in uterine carcinosarcoma [ J ]. Int J Gyne- col Pathol,2013 ,32 :493-500.
  • 5Kato H, Arao T, Matsumoto K, et al. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma [ J ]. Int J Oncol,2013,42 : 1151 - 1158.
  • 6Poza-Guedes P, Barrios Y, Fuentes V, et al. Downregulation of angiogenesis factors, VEGF and PDGF, after rapid IgE desensitization and oral immunotherapy in children with food allergy [ J]. Biomed Res Int,2014,15:805-813.
  • 7Li H, Takayma K, Wang S, et al. Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancerxenografts depending on VEGF expression [ J]. Cancer Chemother Pharmacol,2014,74 : 1297-1305.
  • 8Zhou AP, Feng FY. Advances in clinical research of molecu- lar targeted therapy for metastatic colorectal cancer [ J ]. Cancer Res Clin,2010 ,22 :436-439.
  • 9Maae E, Olsen DA, Steffensen KD,et al. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer [ J ]. Breast Cancer Res Treat,2012,/33:257-265.

二级参考文献13

  • 1李琦,李湘平,黄德亮.喉及喉咽部良恶性病变中微血管密度的测量及其意义[J].广东医学,2004,25(7):792-794. 被引量:4
  • 2DING S,LI C,LIN S,et al.Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions[J].Human Pathology,2006,37(7):861-866.
  • 3HUSSEIN M R.Evaluation of angiogenesis in normal and lichen planus skin by CD34 protein immunohistochemistry:preliminary findings[J].Cell Biology International,2007,31(10):1292-1295.
  • 4WEIDNER N,FOLKMAN J,POZZA F,et al.Tumor angiogenesis:A new significant and independent prognostic indicator in early-stage breast carcinoma[J].J Natl Cancer Inst,1992,84(24):1875-1887.
  • 5SCHWERER M J,KRAFT K,MAIER H,et al.Coexpression of cytokeratins typical for columnar and squamous differentiation in sinonasal inverted papillomas[J].Am J Clin Pathol,2001,115(5):747-754.
  • 6HASEGAWA Y,GOTO M,HANAI N,et al.Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer[J].Oral Oncology,2007,43(8):749-756.
  • 7NIVEIRO M,ARANDA F I,PEIR(O) G,et al.Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas[J].Human Pathol,2005,36(10):1090-1095.
  • 8CHAN J K,MAGISTRIS A,LOIZZI V,et al.Mast cell density,angiogenesis,blood clotting,and prognosis in women with advanced ovarian cancer[J].Gynecol Oncol,2005,99(1):20-25.
  • 9HUSSEIN M R.Evaluation of angiogenesis in normal and lichen planus skin by CD34 protein immunohistochemistry:Preliminary findings[J].Cell Biology Int,2007,31(10):1292-1295.
  • 10USHIJIMA C,TSUKAMOTO S,YAMAZAKI K,et al.High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression[J].Lung Cancer,2001,34(2):233-241.

共引文献5

同被引文献25

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部